The crude venom of Bothrops jararacussu (Bjssu) is known to induce muscular paralysis in vitro. Many studies have shown that various substances, including heparin, neutralize the damage caused by snake venom. In the present study, the ability of heparin (Hep) and commercial bothropic antivenom (CBA) to neutralize neuromuscular effects of Bjssu venom, at different time-points, was analyzed. Mouse phrenic nerve-diaphragm preparation was used through a conventional myographic technique, following five different protocols: Group 1 was incubated with Bjssu (40 µg/mL) without any other treatment; Groups 2 and 3 were pretreated with heparin (1 µL/mL) and CBA (120 µL/mL), respectively, for 15 minutes before venom addition; Group 4 after 50% neuromuscular blockade induced by Bjssu crude venom received 1 µL/mL of heparin while Group 5 received a mixture of Hep:CBA:Bjssu. Control preparations (Tyrode) were treated with Hep and CBA (mean ± SEM; n = 3-6). After 120 minutes of venom incubation, Group 1 preparations presented twitch-tension of 12 ± 2%. However, in Groups 2 and 3, the neutralizations were 92 ± 1.9% and 81 ± 6%, respectively. The heparin addition, after 50% neuromuscular blockade by Bjssu, produced 40 ± 6% muscular response after 120 minutes of incubation. Hep:CBA:Bjssu mixture displayed a protective effect of 84 ± 10% against venom action. In conclusion, heparin and commercial bothropic antivenom efficiently neutralized the neurotoxic effects caused by B. jararacussu crude venom, even at different incubation time-points.
INTRODUCTION
In Brazil venomous snakebite accidents represent an important public health problem. About 90% of them are caused by Bothrops snakes and these cases are distributed among different areas of the country (1, 2) .
Bothrops jararacussu is one of the largest species, in relation to size, of crotalid snakes found in southern Brazil, northern Argentina and eastern Paraguay. Its venom has been studied since the early 1900s (3) , and produces envenomation signs and symptoms similar to other Bothrops species (4).
Although B. jararacussu venom provokes no pronounced neurotoxic effects in vivo, it abolishes, both directly and indirectly, evoked muscle contractions in mouse, chick and frog neuromuscular preparations (5, 6) . This activity has been attributed to the presence of phospholipases and myotoxins (6) (7) (8) . Bothropstoxin-I (BthTX-I), the major myotoxin in B. jararacussu venom, is a 13.7 kDa single chain polypeptide capable of forming dimers (6) (7) (8) (9) .
Serum therapy has been used worldwide for decades to treat patients after snakebites (10) . However, in the last few years, many other strategies have been used to minimize the damages caused by these toxins (11) (12) (13) . For example heparin, a natural anticoagulant molecule that, due to its acidity, can neutralize basic phospholipases A 2 , is under intense investigation as an alternative treatment (14) .
In the present study, different types of heparin treatment were examined to prevent the neurotoxic activity of B. jararacussu crude venom. Commercial bothropic antivenom was also used on mouse neuromuscular preparation to enable further comparative analysis. 
MATERIALS AND METHODS

Materials
Mouse Phrenic Nerve-Diaphragm Preparation
Mice were deeply anesthetized with halothane (Cristália, Brazil) and killed by exsanguination to enable obtainment of phrenic nerve-diaphragm preparations (PND) (15) . 
Protocols carried out:
Bjssu crude venom (40 µg/mL); heparin (1 µL/mL) or antivenom (120 µL/mL) was pretreated for 15 minutes before the venom addition;
heparin addition after 50% twitch-tension blockade was induced by Bjssu crude venom; mixture (heparin:antivenom -1:120 µL/mL) and venom (40 µg/mL) were added. All experiments were compared to the three controls (Tyrode solution, heparin and antivenom alone).
Statistical analysis
All data were presented as mean ± SEM of the number of experiments done (three to eight repetitions each protocol). Statistical comparisons were accomplished using ANOVA (repeated measures) with p < 0.05 indicating significance.
RESULTS
Neuromuscular Activity of Mouse Phrenic Nerve-Diaphragm Preparation (PND)
Submitted to Different Treatments Figure 1 shows the results after submitting the nerve-diaphragm preparations to
Tyrode solution, heparin (1 µL/mL), antivenom (120 µL/mL) and B. jaracussu crude venom (40 μg/mL). Note that the preparation treated with commercial antivenom displayed facilitative effect (increase of twitch-tension amplitude). Significant differences between treated and control results were observed (p < 0.05).
Bjssu venom produced 50% neuromuscular blockade in 41.5 ± 2.6 minutes (n = 6), which is ideal for studying the neutralizing capacity of heparin and antivenom.
Indeed, after 120 minutes of incubation, the venom showed 12 ± 2% (n = 6) contractile response. In all protocols the protective effect of heparin against the toxic action of B.
jararacussu venom was observed. In conclusion, this study shows that heparin and commercial bothropic antivenom were capable of neutralizing the neurotoxic effects induced by whole B. jararacussu venom, even when the treatment is examined at different time-points. Heparin showed a more efficient protection than antivenom, considering the lower amount required (1 µL/mL) in relation to antivenom (120 µL/mL).
